RetifanlimabRetifanlimab
Common
Rarity: Common
The most frequent rarity: most Wikipedia articles become Commons.
Rarity follows how well known the article is: its views on the French and English Wikipedia over a year, and the number of languages it exists in.
At a glance
- Class
- Invention
- Domain
- Science and technology
- Knowledge cost
- 1
- In collections
- Nobody has pulled it yet.
What Wikipedia says
Retifanlimab, sold under the brand name Zynyz, is an anti-cancer medication used for the treatment of Merkel cell carcinoma. Retifanlimab is a programmed death receptor-1 (PD-1)–blocking monoclonal antibody.
Excerpt from the Wikipedia article “Retifanlimab”, under the CC BY-SA 4.0 license. Read the article on Wikipedia
Image: Laboratoires Servier, CC BY-SA 3.0, via Wikimedia Commons.
Open free boosters and add Retifanlimab to your collection.
Play for free

